With a population of over 670 million people in ASEAN, the total number of patients experiencing rare diseases and conditions ...

The use of real-world evidence (RWE) began gaining traction decades ago, primarily as a response to the limitation around ...

As the US Centers for Medicare and Medicaid Services (CMS) has released the new prices for 15 drugs that have been added to ...

Corstasis Therapeutics is to collaborate with CVL on the adoption and integration of the Enbumyst nasal spray into heart failure care.

During the UK’s Autumn Budget, Rachel Reeves has unveiled further technology investments for the UK’s National Health Service ...

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

The path from discovery to lifechanging therapy shouldn't be blocked by manufacturing limitations. MasterControl offers ...

Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...

UNICEF and Gavi, the Vaccine Alliance, have announced a pricing deal to expand access to the R21/Matrix-M malaria vaccine.

Developed by UCL spinout Autolus, Aucatzyl will be launched imminently across England and Wales. A UK-developed cell therapy ...

Gilead now own the rights to Sprint's preclinical oncology immunotherapy programme, which targets the novel cancer target, ...